FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292308304> ?p ?o ?g. }

• W4292308304 abstract "Sacubitril-valsartan was recommended for heart failure (HF) and proven cost-effective in HF. Recently, sacubitril-valsartan has been recommended to treat hypertension by the Chinese expert consensus. The cost utility of sacubitril-valsartan for hypertension remains uninvestigated.A meta-analysis of randomized controlled trials (RCTs) was performed to investigate the real efficacy of sacubitril-valsartan on blood pressure, compared with angiotensin receptor blockers or placebo. A lifetime Markov model was developed to compare the cost utility of sacubitril-valsartan vs. valsartan. The primary outcome was the incremental cost-utility ratio (ICUR), representing the ratio of incremental costs to the incremental utility. The willingness-to-pay (WTP) threshold was three times of per capita gross domestic product (GDP) in China in 2021. Sacubitril-valsartan was considered cost-effective if the ICUR obtained was lower than the WTP threshold, otherwise, sacubitril-valsartanis was not cost-effective.A total of 10 RCTs of 5,781 patients were included in the meta-analysis. For comparison of sacubitril-valsartan 400 mg/day vs. valsartan 320 mg/day, a reduction in blood pressure (BP) of -5.97 (-6.38, -5.56) (p < 0.01) was observed. Cost-utility analysis showed that for a 60-year-old patient with hypertension, if sacubitril-valsartan was prescribed as the antihypertensive agent, he had a life expectancy of 11.91 quality-adjusted life-years (QALYs) with costs of 65,066 CNY, and if valsartan was prescribed as the antihypertensive agent, the life expectancy would be 11.82 QALY with costs of 54,769 CNY; thus, an ICUR of 108,622 CNY/QALY was obtained, lower than the WTP threshold.Compared with valsartan, sacubitril-valsartan is more effective in reducing blood pressure and may result in more quality-adjusted life-year, although with higher costs. Sacubitril-valsartan is cost-effective for hypertension in the current China setting under the willingness-to-pay threshold of 3 times of per capita GDP." @default.
• W4292308304 created "2022-08-19" @default.
• W4292308304 creator A5007772241 @default.
• W4292308304 creator A5031646590 @default.
• W4292308304 creator A5073144090 @default.
• W4292308304 creator A5083868441 @default.
• W4292308304 date "2022-08-17" @default.
• W4292308304 modified "2023-09-30" @default.
• W4292308304 title "Sacubitril-valsartan for the treatment of hypertension in China: A cost-utility analysis based on meta-analysis of randomized controlled trials" @default.
• W4292308304 cites W1033174547 @default.
• W4292308304 cites W2110566665 @default.
• W4292308304 cites W2113698123 @default.
• W4292308304 cites W2125435699 @default.
• W4292308304 cites W2550466917 @default.
• W4292308304 cites W2566524830 @default.
• W4292308304 cites W2569387348 @default.
• W4292308304 cites W2587590725 @default.
• W4292308304 cites W2592637343 @default.
• W4292308304 cites W2600026896 @default.
• W4292308304 cites W2734349140 @default.
• W4292308304 cites W2757773166 @default.
• W4292308304 cites W2766721694 @default.
• W4292308304 cites W2784157249 @default.
• W4292308304 cites W2903695790 @default.
• W4292308304 cites W2977261765 @default.
• W4292308304 cites W2989847253 @default.
• W4292308304 cites W3004465995 @default.
• W4292308304 cites W3023529892 @default.
• W4292308304 cites W3043902343 @default.
• W4292308304 cites W3045345078 @default.
• W4292308304 cites W3157857666 @default.
• W4292308304 cites W3164570271 @default.
• W4292308304 cites W3176842997 @default.
• W4292308304 cites W3193598686 @default.
• W4292308304 cites W3196700603 @default.
• W4292308304 cites W3198533772 @default.
• W4292308304 cites W3201459780 @default.
• W4292308304 cites W3204324739 @default.
• W4292308304 cites W4200213577 @default.
• W4292308304 cites W4205990342 @default.
• W4292308304 cites W4210733723 @default.
• W4292308304 cites W4224214088 @default.
• W4292308304 cites W4225391197 @default.
• W4292308304 cites W4281977150 @default.
• W4292308304 cites W4292308390 @default.
• W4292308304 doi "https://doi.org/10.3389/fpubh.2022.959139" @default.
• W4292308304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36062091" @default.
• W4292308304 hasPublicationYear "2022" @default.
• W4292308304 type Work @default.
• W4292308304 citedByCount "2" @default.
• W4292308304 countsByYear W42923083042023 @default.
• W4292308304 crossrefType "journal-article" @default.
• W4292308304 hasAuthorship W4292308304A5007772241 @default.
• W4292308304 hasAuthorship W4292308304A5031646590 @default.
• W4292308304 hasAuthorship W4292308304A5073144090 @default.
• W4292308304 hasAuthorship W4292308304A5083868441 @default.
• W4292308304 hasBestOaLocation W42923083041 @default.
• W4292308304 hasConcept C112930515 @default.
• W4292308304 hasConcept C126322002 @default.
• W4292308304 hasConcept C168563851 @default.
• W4292308304 hasConcept C2775999527 @default.
• W4292308304 hasConcept C2776754050 @default.
• W4292308304 hasConcept C2777387769 @default.
• W4292308304 hasConcept C3019080777 @default.
• W4292308304 hasConcept C515549039 @default.
• W4292308304 hasConcept C71924100 @default.
• W4292308304 hasConcept C84393581 @default.
• W4292308304 hasConceptScore W4292308304C112930515 @default.
• W4292308304 hasConceptScore W4292308304C126322002 @default.
• W4292308304 hasConceptScore W4292308304C168563851 @default.
• W4292308304 hasConceptScore W4292308304C2775999527 @default.
• W4292308304 hasConceptScore W4292308304C2776754050 @default.
• W4292308304 hasConceptScore W4292308304C2777387769 @default.
• W4292308304 hasConceptScore W4292308304C3019080777 @default.
• W4292308304 hasConceptScore W4292308304C515549039 @default.
• W4292308304 hasConceptScore W4292308304C71924100 @default.
• W4292308304 hasConceptScore W4292308304C84393581 @default.
• W4292308304 hasLocation W42923083041 @default.
• W4292308304 hasLocation W42923083042 @default.
• W4292308304 hasLocation W42923083043 @default.
• W4292308304 hasLocation W42923083044 @default.
• W4292308304 hasOpenAccess W4292308304 @default.
• W4292308304 hasPrimaryLocation W42923083041 @default.
• W4292308304 hasRelatedWork W2563448326 @default.
• W4292308304 hasRelatedWork W2809099805 @default.
• W4292308304 hasRelatedWork W2965519287 @default.
• W4292308304 hasRelatedWork W2977261765 @default.
• W4292308304 hasRelatedWork W3043902343 @default.
• W4292308304 hasRelatedWork W3201459780 @default.
• W4292308304 hasRelatedWork W3204664938 @default.
• W4292308304 hasRelatedWork W4292308304 @default.
• W4292308304 hasRelatedWork W4294584637 @default.
• W4292308304 hasRelatedWork W4322773649 @default.
• W4292308304 hasVolume "10" @default.
• W4292308304 isParatext "false" @default.
• W4292308304 isRetracted "false" @default.
• W4292308304 workType "article" @default.